On Friday, Procept BioRobotics Corp (NASDAQ: PRCT) opened higher 3.53% from the last session, before settling in for the closing price of $85.91. Price fluctuations for PRCT have ranged from $31.57 to $103.81 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 142.74% annually for the last half of the decade. Company’s average yearly earnings per share was noted 21.80% at the time writing. With a float of $51.32 million, this company’s outstanding shares have now reached $54.39 million.
In an organization with 626 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 56.09%, operating margin of -53.27%, and the pretax margin is -50.07%.
Procept BioRobotics Corp (PRCT) Insider Updates
A key investor’s attitude towards the stock of the Medical Devices industry is another important factor to consider. The insider ownership of Procept BioRobotics Corp is 5.66%, while institutional ownership is 84.45%. The most recent insider transaction that took place on Nov 13 ’24, was worth 2,485,573. In this transaction President, CEO of this company sold 26,420 shares at a rate of $94.08, taking the stock ownership to the 232,025 shares. Before that another transaction happened on Nov 13 ’24, when Company’s Director proposed sale 26,420 for $95.55, making the entire transaction worth $2,524,431.
Procept BioRobotics Corp (PRCT) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around 21.80% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 26.50% during the next five years compared to -23.27% drop over the previous five years of trading.
Procept BioRobotics Corp (NASDAQ: PRCT) Trading Performance Indicators
Check out the current performance indicators for Procept BioRobotics Corp (PRCT). In the past quarter, the stock posted a quick ratio of 5.07. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 25.06.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.95, a number that is poised to hit -0.34 in the next quarter and is forecasted to reach -1.38 in one year’s time.
Technical Analysis of Procept BioRobotics Corp (PRCT)
Let’s dig in a bit further. During the last 5-days, its volume was 0.88 million. That was better than the volume of 0.66 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 13.48%. Additionally, its Average True Range was 5.24.
During the past 100 days, Procept BioRobotics Corp’s (PRCT) raw stochastic average was set at 70.13%, which indicates a significant increase from 17.66% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 59.90% in the past 14 days, which was lower than the 74.85% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $80.97, while its 200-day Moving Average is $64.81. However, in the short run, Procept BioRobotics Corp’s stock first resistance to watch stands at $90.63. Second resistance stands at $92.33. The third major resistance level sits at $94.52. If the price goes on to break the first support level at $86.74, it is likely to go to the next support level at $84.55. Assuming the price breaks the second support level, the third support level stands at $82.85.
Procept BioRobotics Corp (NASDAQ: PRCT) Key Stats
There are currently 52,183K shares outstanding in the company with a market cap of 5.01 billion. Presently, the company’s annual sales total 136,190 K according to its annual income of -105,900 K. Last quarter, the company’s sales amounted to 58,370 K and its income totaled -20,970 K.
